Teemu Kantola
- Pharmacology top 0.5%
- Surgery top 10%
- Oncology top 10%
- Pediatrics, Perinatology and Child Health top 5%
- Economics and Econometrics top 5%
- Co-authors
- Pertti J. NeuvonenKari T. KivistöTommi LambergK. HöckerstedtHelena IsoniemiTaru KantolaAnna‐Maria KoivusaloKilian Guse
- Topics
- Pharmacogenetics and Drug Metabolism (4 papers)Virus-based gene therapy research (3 papers)Pharmaceutical Economics and Policy (3 papers)
In The Last Decade
Teemu Kantola
10 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Pharmacology 538
- Surgery 426
- Oncology 355
- Pediatrics, Perinatology and Child Health 191
- Economics and Econometrics 175
Countries citing papers authored by Teemu Kantola
This map shows the geographic impact of Teemu Kantola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teemu Kantola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teemu Kantola more than expected).
Fields of papers citing papers by Teemu Kantola
This network shows the impact of papers produced by Teemu Kantola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teemu Kantola. The network helps show where Teemu Kantola may publish in the future.
Co-authorship network of co-authors of Teemu Kantola
This figure shows the co-authorship network connecting the top 25 collaborators of Teemu Kantola. A scholar is included among the top collaborators of Teemu Kantola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teemu Kantola. Teemu Kantola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 26 | |
| 3 | 24 | |
| 4 | 2 | |
| 5 | Treatment of cancer patients with capsid modified double controlled oncolytic adenovirus Ad5/3-Cox2L-D24 | 1 |
| 6 | 323 | |
| 7 | 225 | |
| 8 | 205 | |
| 9 | 240 | |
| 10 | 104 |
About Teemu Kantola
Teemu Kantola is a scholar working on Pharmacology, Emergency Medicine and Neurology, having authored 10 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Virus-based gene therapy research (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Pharmacology (538 citations), Geriatrics and Gerontology (51 citations) and Oncology (355 citations). Teemu Kantola has collaborated with scholars based in Finland and Germany. Frequent co-authors include Pertti J. Neuvonen, Kari T. Kivistö, Kari T. Kivistö, Tommi Lamberg, K. Höckerstedt, Helena Isoniemi, Taru Kantola, Anna‐Maria Koivusalo, Kilian Guse and Anna Kanerva. Their work appears in journals such as Cancer Research, Clinical Pharmacology & Therapeutics and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.